Welcome to our dedicated page for Danaher Corporation SEC filings (Ticker: DHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Danaher鈥檚 10-K can exceed 250 pages, weaving life-sciences revenue, diagnostics margins, and dozens of recent acquisitions into dense footnotes. Finding how Cytiva lifted bioprocessing sales or when executives exercise options is time-consuming. Stock Titan decodes every Danaher SEC filing, turning complexity into clarity.
Our platform delivers AI-powered summaries that make Danaher SEC filings explained simply. Need the latest Danaher quarterly earnings report 10-Q filing? We tag segment performance so you can compare consumables growth quarter-over-quarter. Tracking governance? Get Danaher proxy statement executive compensation highlights in plain English. Material event on a new acquisition? See the Danaher 8-K material events explained the moment it posts to EDGAR. And because insider activity moves the stock, our alerts surface Danaher insider trading Form 4 transactions鈥攊苍肠濒耻诲颈苍驳 Danaher Form 4 insider transactions real-time鈥攂efore the market digests them.
Investors use these insights to:
- Monitor R&D intensity versus peers with Danaher annual report 10-K simplified
- Spot integration costs from recent M&A using Danaher earnings report filing analysis
- Review Danaher executive stock transactions Form 4 ahead of earnings calls
- Understand environmental disclosures and DBS efficiency metrics without reading every footnote
Whether you鈥檙e understanding Danaher SEC documents with AI for strategic research or scanning for trading catalysts, Stock Titan provides real-time updates, expert context, and the confidence to act on every disclosure.
Teri List, a director of Danaher Corporation (DHR), reported a sale of 2,778 shares of Danaher common stock on 08/22/2025 at a reported price of $211.058 per share. After the sale, the reporting person beneficially owned 20,750.672 shares, held directly. The Form 4 was signed by an attorney-in-fact on 08/25/2025.
Danaher Corporation (DHR) Form 144 notice reports a proposed sale of 2,778 shares of common stock through Fidelity Brokerage Services LLC on 08/22/2025 on the NYSE with an aggregate market value of $586,319.96. The shares were acquired by stock option exercise from the issuer on 07/02/2025 and were paid for in cash on that date. The filing lists the total number of shares outstanding as 716,051,590. The form indicates no securities sold during the past three months for the account and includes the statutory representation that the seller has no undisclosed material adverse information.
FAQ
What is the current stock price of Danaher Corporation (DHR)?
What is the market cap of Danaher Corporation (DHR)?
